Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

cipla medpro (pty) ltd - powder - 2,5 iu - each 1,0 ml dose contains purified rabies antigen (rabies virus pitman-moore strain 3218) =2,5 iu

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) - powder for injection with diluent - 3.25 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) excipient: albumin hydrochloric acid bme medium - mineral salts, vitamins, amino acids including l-phenylalanine maltose sodium hydroxide sodium chloride water for injection - verorab is indicated for pre-exposure and post-exposure prophylaxis against rabies in all age groups. verorab should be used in accordance with official local recommendations. generally, pre-exposure prophylaxis should be offered to people at high risk of exposure such as those working in rabies diagnostic or research laboratories, veterinarians, animal handlers potentially exposed to rabid animals, as well as other people (especially children) living in or traveling to high-risk areas.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - rabies vaccine 2.5 [iu] - injection with diluent - 2.5 iu - active: rabies vaccine 2.5 [iu] excipient: disodium edetate potassium l-glutamate polygeline sodium chloride sucrose trometamol water for injection - active immunisation against rabies virus, including (a) pre-exposure immunisation, (b) post-exposure treatment following exposure to rabies virus

Israel - engelsk - Ministry of Health

omrix biopharmaceuticals - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 50 mg/ml mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy * primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinemia or hypogammaglobulinemia) * myeloma or chronic lymphocytic leukemia (cll) with severe secondary hypogammaglobulinemia and recurrent infections. * children with congenital aids and recurrent infections - immunomodulation * idiopathic thrombocytopenic purpura (itp) * guillain barre syndrome * kawasaki disease - allogenic bone marrow transplantation

Canada - engelsk - Health Canada

aventis pasteur limited - rabies vaccine inactivated (human diploid-cell culture) - powder for solution - 2.5unit - rabies vaccine inactivated (human diploid-cell culture) 2.5unit - vaccines

USA - engelsk - NLM (National Library of Medicine)

grifols usa, llc - human rabies virus immune globulin (unii: 95f619atq2) (human rabies virus immune globulin - unii:95f619atq2) - human rabies virus immune globulin 150 [iu] in 1 ml - rabies vaccine and hyperrab s/d should be given to all persons suspected of exposure to rabies with one exception: persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer should receive only vaccine. hyperrab s/d should be administered as promptly as possible after exposure, but can be administered up to the eighth day after the first dose of vaccine is given. recommendations for use of passive and active immunization after exposure to an animal suspected of having rabies have been detailed by the u.s. public health service advisory committee on immunization practices (acip). [19] every exposure to possible rabies infection must be individually evaluated. the following factors should be considered before specific antirabies treatment is initiated: carnivorous wild animals (especially skunks, foxes, coyotes, raccoons, and bobcats) and bats are the animals most commonly infected with rabies and have caused most of the indigenous cases of human rabies

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe s.a. - rabies virus (inactivated) ; albumin human 50 mg - powder and solvent for solution for injection - rabies virus, inactivated - rabies, inactivated, whole virus

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - rabies virus (inactivated) >= 2 iu/dose - suspension for injection - rabies virus, inactivated - rabies virus - cattle; dog; horse; cat; sheep

Indien - engelsk - Central Drugs Standard Control Organization

gen bio. - rabies immunoglobulin - vaccine - anti rabies serum - single dose via syringe diluent

Indien - engelsk - Central Drugs Standard Control Organization

ranbaxy - rabies immunoglobulin - 300iu. (human rabies ig 300iu.) - 2ml